vaccin
pivot
develop
modern
medicin
gener
childhood
vaccin
global
erad
smallpox
near
elimin
polio
nonetheless
success
vaccin
major
target
malaria
human
immunodefici
viru
hiv
yet
recent
zika
viru
outbreak
highlight
need
ongo
vaccin
relat
global
rise
antimicrobi
resist
reli
medic
alon
treat
diseas
contract
guarante
thu
continu
vaccin
develop
still
import
area
basic
appli
tradit
vaccin
base
administr
kill
attenu
organ
purifi
compon
proven
among
effect
method
diseas
howev
number
safeti
issu
relat
product
administr
vaccin
limit
univers
applic
includ
risk
revers
virul
organ
decreas
alter
immun
respons
inactiv
possibl
caus
diseas
immun
compromis
individu
requir
maintain
cold
recent
advanc
identif
singl
compon
antigen
capabl
gener
protect
immun
driven
develop
subunit
vaccin
instead
use
whole
pathogen
specif
portion
deliv
use
furthermor
improv
genet
method
express
system
result
cheaper
product
recombin
microbi
antigen
without
need
cultur
highli
pathogen
infecti
despit
advantag
recombin
subunit
vaccin
often
less
immunogen
tradit
counterpart
overcom
decreas
immunogen
subunit
vaccin
requir
addit
immunostimulatori
agent
ie
optim
deliveri
system
specif
target
immun
cell
tailor
immun
anoth
key
strategi
subunit
vaccin
design
creat
multival
platform
enabl
express
multipl
antigen
repetit
deliveri
system
sever
copi
antigen
differ
strain
pathogen
could
gener
immun
increas
immunogen
vaccin
requir
platform
could
adapt
display
antigen
immunopotenti
receptor
thu
enhanc
activ
uptak
present
antigen
immun
system
adopt
strategi
direct
antigen
deliveri
releas
may
stimul
potent
immun
respons
use
lower
dose
weak
immunogen
reduc
need
prime
boost
strategi
often
requir
convent
vaccin
regimen
would
lead
benefici
reduc
develop
cost
improv
immun
effici
schedul
event
vaccin
subunit
vaccin
deliveri
system
typic
includ
use
peptid
rational
mimic
size
shape
virus
simul
immun
respons
similar
live
attenu
vaccin
maintain
select
subunit
vaccin
protein
engin
design
approach
particular
provid
increas
synthet
access
control
one
exampl
protein
nanoparticl
sapn
sapn
compris
trimer
pentamer
motif
link
singl
peptid
polypeptid
assembl
particl
nm
diamet
optim
act
vaccin
carrier
biodistribut
vivo
serv
repetit
antigen
display
capabl
induc
varieti
immun
respons
includ
particl
modifi
epitop
deriv
sever
acut
respiratori
syndrom
influenza
viru
qv
system
potenti
function
structur
take
form
nanofib
tube
rather
resembl
viral
capsid
assembl
exploit
thermal
environment
synthet
peptid
system
along
dose
incorpor
exampl
demonstr
potenti
synthet
peptid
vaccin
deliveri
platform
work
describ
herein
explor
potenti
peptid
cage
sage
act
modular
scaffold
synthet
biolog
approach
antigen
deliveri
sage
made
de
novo
peptid
specif
set
homotrimer
heterodimer
peptid
link
via
disulfid
bond
form
two
complementari
mix
hub
aqueou
solut
lead
hexagon
ultim
fold
spheric
particl
nm
diamet
figur
work
hypothesi
sage
architectur
unit
orient
within
peptid
lattic
n
terminu
face
exterior
particl
c
terminu
face
interior
greater
freedom
rotat
around
disulfid
subsequ
function
incorpor
via
allow
bespok
dose
deliveri
antigen
dose
control
via
peptid
synthesi
conjug
rather
passiv
fulli
synthet
sage
appear
withstand
rel
robust
function
qv
predict
modifi
alter
cellular
uptak
qv
modular
system
allow
fine
control
sage
potenti
altern
platform
develop
subunit
vaccin
follow
advantag
modular
mean
mix
differ
ratio
hub
build
block
incorpor
multipl
antigen
thu
tailor
immun
respons
furthermor
natur
sage
structur
provid
multival
platform
potenti
use
deliv
multipl
antigen
differ
strain
therebi
increas
antigen
immunogen
anoth
import
consider
compon
stabil
hub
build
block
lyophil
store
powder
could
also
benefit
platform
avoid
problem
associ
cold
chain
investig
potenti
sage
scaffold
vaccin
platform
whether
sage
function
model
antigen
peptid
success
deliv
drive
specif
immun
respons
result
show
sage
nontox
capabl
enhanc
immun
respons
vitro
vivo
model
antigen
peptid
sage
function
model
antigen
peptid
epitop
achiev
extend
peptid
sequenc
epitop
peptid
synthesi
spp
sage
design
synthes
function
ad
either
n
c
terminu
termini
figur
tabl
figur
support
inform
vitro
work
use
model
antigen
peptid
tetanu
tt
cell
epitop
vivo
experi
use
model
antigen
peptid
ova
cell
epitop
influenza
viru
cell
epitop
last
epitop
short
sequenc
herp
simplex
viru
dna
polymeras
includ
maxim
effect
proteasom
process
present
major
histocompat
receptor
class
extend
peptid
ha
use
addit
vivo
experi
function
peptid
subject
biophys
character
conjug
peptid
make
hub
first
circular
dichroism
cd
spectroscopi
use
test
impact
trimer
compon
function
trimer
monitor
helic
function
peptid
mean
residu
ellipt
mre
deg
nm
record
spectra
observ
signal
consist
fold
append
unfold
peptid
figur
tabl
support
inform
peptid
stabil
greatli
alter
observ
compar
midpoint
unfold
temperatur
thermal
denatur
experi
figur
tabl
support
inform
function
hub
similarli
assess
found
unaffect
figur
tabl
support
inform
function
peptid
analyz
use
sediment
veloc
analyt
ultracentrifug
auc
figur
support
inform
predomin
peak
tt
peptid
trimer
peptid
show
addit
smaller
speci
peptid
appear
form
discret
trimer
solut
thermal
stabil
drastic
alter
possibl
addit
ova
affect
abil
peptid
trimer
assembl
function
sage
particl
assess
scan
electron
microscopi
sem
dynam
light
scatter
dl
sem
sage
produc
particl
compar
size
parent
sage
form
slightli
larger
particl
sage
form
much
larger
particl
figur
data
obtain
dl
measur
often
gave
rang
particl
size
within
sampl
possibl
determin
particl
size
experi
figur
support
inform
hydrodynam
diamet
increas
compar
individu
hub
techniqu
demonstr
abil
particl
form
aggreg
techniqu
aggreg
sampl
meant
possibl
accur
determin
particl
size
howev
overal
suit
biophys
character
confirm
sage
modifi
model
antigen
peptid
compet
particl
vitro
studi
sage
uptak
hela
cell
show
qv
sage
toxic
cell
type
assess
use
human
peripher
blood
mononuclear
cell
pbmc
isol
whole
blood
pbmc
expos
polyclon
stimulu
phytohemagglutinin
pha
induc
respons
indic
cell
prolifer
presenc
absenc
sage
pbmc
abl
prolifer
respons
pha
irrespect
sage
concentr
confirm
assembl
particl
toxic
figur
assess
whether
sage
intrins
immunogen
rest
pbmc
cultur
parent
sage
rang
concentr
determin
prolifer
induc
pbmc
prolifer
observ
concentr
higher
sage
concentr
give
greatest
prolif
respons
figur
abil
sage
stimul
pbmc
prolifer
may
attribut
either
weak
inher
immunogen
mitogen
sourc
prolifer
probe
assay
sage
compon
build
block
huba
hubb
constitu
peptid
compon
abil
stimul
prolifer
pbmc
assay
figur
along
immunolog
memori
respons
human
mous
sera
figur
e
prolif
respons
sage
found
due
particular
peptid
compon
posit
sage
may
induc
respons
due
shape
size
local
concentr
result
propos
abil
sage
prompt
immun
respons
would
benefici
develop
vaccin
deliveri
platform
potenti
similar
manner
employ
conjug
sage
toxic
vivo
also
assay
immun
mice
extrem
dose
parent
sage
balbc
mice
immun
four
dose
parent
sage
dose
interv
week
week
final
immun
serum
aspart
aminotransferas
ast
level
use
evalu
liver
function
compar
five
mice
control
phosphat
buffer
salin
pb
three
mice
anim
figur
immun
lead
alter
percentag
lymphocyt
monocyt
popul
number
peripher
blood
figur
support
inform
immun
mice
develop
inject
site
reaction
advers
system
effect
combin
lack
histopatholog
chang
tabl
support
inform
data
suggest
sage
toxic
vivo
antigen
present
cell
apc
immun
phagocyt
intern
process
present
foreign
materi
immun
cell
establish
parent
sage
nontox
potenti
immunogenicmitogen
explor
whether
immun
phagocyt
intern
prime
sage
particl
human
pbmc
purifi
differenti
dendrit
cell
mddc
macrophag
mdm
monitor
cellular
uptak
particl
hub
build
block
replac
fluoresc
label
counterpart
assembl
fitcsag
tabl
support
inform
cellular
uptak
quantifi
flow
cytometri
isol
intern
fluoresc
quench
extern
fluoresc
trypan
blue
figur
mddc
mdm
took
sage
similar
kinet
greatest
rate
uptak
first
min
howev
mdm
greater
overal
uptak
sage
compar
mddc
although
mddc
mdm
known
phagocyt
cell
uptak
nanoparticl
influenc
particl
size
aggreg
state
addit
matur
state
may
explain
differ
sage
uptak
observ
next
investig
whether
phagocyt
activ
sage
uptak
determin
increas
secret
rang
cytokin
increas
surfac
express
antigen
present
molecul
mddc
mdm
cultur
sage
follow
analysi
marker
cytokin
supernat
cytokin
secret
mddc
mdm
induc
sage
treatment
cell
posit
control
lipopolysaccharid
lp
increas
amount
secret
figur
support
inform
phagocyt
cell
shown
upregul
molecul
mhc
class
ii
express
observ
effect
moder
comparison
effect
lp
figur
support
inform
combin
experi
confirm
mdm
mddc
intern
sage
particl
weakli
activ
demonstr
potenti
sage
deliveri
platform
vaccin
test
whether
sage
would
alter
phagocyt
uptak
downstream
respons
use
pbmc
flow
cytometri
compar
previou
experi
figur
observ
enhanc
uptak
parent
sage
mdm
figur
like
due
donor
variabl
taken
effect
parent
sage
min
taken
significantli
less
well
timepoint
figur
final
timepoint
construct
tt
function
intern
mddc
less
rapidli
function
consist
work
model
sage
assembl
structur
surfac
particl
alter
modif
possibl
affect
particl
uptak
mddc
test
whether
differ
uptak
function
sage
affect
downstream
respons
prolif
abil
human
pbmc
determin
exposur
three
sage
figur
pbmc
prolifer
indic
cell
respons
case
consid
cell
respons
tt
peptid
model
cell
experiment
control
parent
sage
free
tt
peptid
parent
sage
mix
free
tt
peptid
elicit
low
level
cellular
prolifer
equival
amount
tt
parent
sage
tt
free
tt
peptid
control
amount
sage
peptid
equival
construct
control
doubl
amount
tt
rel
singli
function
counterpart
two
construct
induc
significantli
greater
prolif
respons
free
tt
peptid
doubli
function
induc
higher
prolif
respons
singli
function
though
differ
signific
function
suspect
affect
intern
despit
deliv
dosag
signific
differ
respons
conclud
less
effect
uptak
impact
downstream
prolif
respons
result
vitro
experi
confirm
apc
abl
intern
function
sage
drive
downstream
respons
data
provid
first
evid
sage
potenti
vaccin
scaffold
deliv
antigen
compon
test
respons
vivo
immunogen
parent
sage
anim
model
assess
immun
primeboost
regimen
group
balbc
mice
either
immun
parent
sage
day
day
day
assay
splenocyt
prolifer
antibodi
titer
anim
immun
booster
dose
sage
show
increas
prolifer
splenocyt
restimul
ex
vivo
sage
particl
figur
furthermor
primeboost
regimen
also
gener
signific
increas
product
antibodi
follow
singl
immun
figur
base
result
experi
function
sage
also
perform
primeboost
regimen
order
bolster
desir
immun
respons
sage
design
synthes
contain
either
n
epitop
follow
promis
result
observ
two
copi
ova
epitop
conjug
increas
deliv
dose
balbc
mice
prime
boost
dose
ova
either
form
sage
free
ova
peptid
free
peptid
deliv
without
complet
freund
adjuv
cfa
addit
control
group
immun
parent
sage
splenocyt
prolifer
monitor
measur
cell
case
cell
respons
ova
antigen
splenocyt
mice
given
sage
form
abl
gener
prolif
respons
restimul
sage
ex
vivo
figur
produc
antibodi
figur
antibodi
respons
also
observ
mice
immun
ova
cfa
despit
receiv
sage
form
believ
due
use
adjuv
result
overal
higher
concentr
antibodi
sera
turn
low
level
nonspecif
bind
parallel
splenocyt
also
restimul
ex
vivo
ova
peptid
figur
mice
given
free
ova
peptid
cfa
mount
strongest
prolif
respons
expect
use
adjuv
howev
respons
free
ova
peptid
without
cfa
enhanc
immun
equival
dose
form
sage
particl
mice
given
sage
also
produc
antibodi
figur
posit
control
free
ova
peptid
cfa
gener
greatest
antibodi
titer
sage
gave
significantli
greater
respons
free
ova
peptid
result
demonstr
potenti
sage
system
deliveri
platform
capabl
enhanc
immun
respons
compar
equival
amount
free
immunogen
peptid
greater
respons
term
cell
prolifer
antibodi
product
observ
ova
deliv
part
function
sage
free
peptid
stimul
stronger
cell
prolif
respons
figur
stimul
greater
antibodi
product
figur
result
contradictori
sage
improv
respons
rel
free
ova
peptid
case
experi
demonstr
effect
uptak
process
function
sage
vivo
drive
respons
abil
drive
cell
antibodi
respons
show
promis
sage
vaccin
deliveri
system
next
sage
function
mhc
class
epitop
test
whether
platform
could
also
enhanc
prime
cell
respons
vivo
transgen
mice
use
test
respons
sage
function
extend
sage
function
singl
copi
ha
c
terminu
mhc
class
process
specif
mhc
class
ii
far
test
posit
epitop
effect
end
util
transgen
clone
cell
express
cell
receptor
tcr
ha
epitop
accordingli
cell
cell
label
prolifer
marker
celltrac
violet
ctv
cell
divid
prime
daughter
cell
contain
less
label
becom
distinguish
undivid
fulli
label
unprim
cell
balbc
mice
inject
intraven
iv
purifi
cell
mice
simultan
immun
subcutan
sc
either
ha
peptid
alon
deliv
ng
ha
per
mous
respect
establish
appropri
dose
use
transgen
cell
allow
greatli
reduc
dose
compar
previou
experi
cell
prime
respond
particular
epitop
cell
isol
spleen
mice
extent
prolifer
determin
flow
cytometr
analys
ctv
express
data
show
mice
immun
ha
peptid
alon
cell
prolifer
respons
concentr
peptid
evidenc
shift
cell
left
panel
result
loss
ctv
figur
howev
mice
immun
even
greater
cell
prolifer
concentr
compar
mice
immun
ha
peptid
alon
evidenc
appear
discret
popul
highli
divid
cell
figur
left
dash
line
inde
analys
either
ha
peptid
show
signific
increas
percentag
highli
divid
cell
mice
immun
compar
immun
ha
alon
figur
data
therefor
demonstr
function
sage
epitop
enhanc
deliveri
vivo
collect
result
obtain
use
ha
sage
show
sage
capabl
enhanc
rang
differ
immun
respons
vivo
work
describ
herein
explor
one
potenti
applic
sage
nanoparticl
compris
de
novo
peptid
subunit
vaccin
instead
use
whole
pathogen
util
scaffold
deliv
pathogen
compon
use
sage
scaffold
offer
synthet
biolog
approach
subunit
vaccin
develop
protein
cage
modifi
deliv
immunogen
compon
modular
sage
allow
control
dose
deliveri
addit
possibl
multival
system
demonstr
potenti
sage
act
antigen
deliveri
platform
vitro
vivo
toxic
assay
ex
vivo
immunogen
screen
use
function
sage
probe
rang
immun
respons
model
antigen
peptid
vitro
experi
use
model
tetanu
toxoid
antigen
tt
confirm
apc
abl
intern
function
sage
though
posit
function
may
affect
uptak
howev
importantli
experi
show
function
sage
still
intern
mddc
particl
effect
process
drive
downstream
cell
respons
addit
respons
sage
greater
equival
dose
free
tt
peptid
futur
work
look
improv
uptak
consist
enhanc
downstream
respons
includ
target
mddc
cleavabl
linker
sage
function
model
ovalbumin
antigen
ova
abl
drive
stronger
immun
respons
vivo
equival
amount
ova
peptid
includ
cell
b
cell
respons
howev
demonstr
abil
drive
respons
vivo
data
sage
highlight
need
increas
dose
antigen
rel
sage
per
immun
ongo
work
seek
function
sage
antigen
protein
compon
increas
ratio
peptid
process
antigen
rather
sage
form
major
peptid
present
apc
surfac
import
consider
new
vaccin
optim
econom
effici
immun
schedul
work
investig
role
sage
immunogenicitymitogen
respons
establish
primeboost
regimen
appropri
anticip
provid
protect
platform
must
abl
drive
rang
immun
respons
build
observ
cell
b
cell
respons
incorpor
cell
epitop
influenza
viru
hemagglutinin
sage
architectur
via
extend
peptid
enhanc
epitop
deliveri
ha
adopt
transfer
assay
prolif
respons
transgen
cell
prime
recogn
epitop
encourag
increas
respons
rel
free
ha
peptid
believ
ad
abil
enhanc
cell
respons
give
system
potenti
vaccin
scaffold
optim
anticip
exploit
modular
system
target
multipl
branch
immun
system
protect
challeng
might
take
form
particl
compris
hub
multipl
antigen
function
use
whole
protein
function
increas
immunogen
respons
lyophil
particl
function
whole
protein
must
investig
work
describ
herein
use
antigen
peptid
demonstr
withstand
process
posit
sage
function
effect
uptak
importantli
downstream
respons
area
futur
work
investig
base
stricter
process
mhc
class
antigen
reflect
work
de
haan
et
ha
epitop
incorpor
sage
howev
sage
function
tt
ova
n
allow
comparison
effect
antigen
posit
downstream
immun
respons
vitro
experi
sage
suggest
function
decreas
uptak
sage
lead
diminish
abil
stimul
cell
prolifer
contrast
sage
function
ova
stimul
stronger
cell
prolif
respons
weaker
antibodi
respons
compar
sage
function
ova
sage
uptak
apc
explor
much
detail
tt
function
result
suggest
ova
affect
uptak
level
way
tt
measur
downstream
immun
respons
know
biophys
character
ova
function
lead
format
larger
particl
potenti
destabil
effect
compon
trimer
would
interest
probe
mechan
intern
whether
function
affect
particl
recognit
cellular
uptak
due
surfac
charg
differ
particl
size
aggreg
remain
identifi
de
novo
design
sage
system
provid
adapt
predict
modular
system
easili
access
interchang
compon
part
compon
access
synthet
recombinantli
suscept
problem
associ
cold
chain
modifi
success
display
antigen
modular
sage
mean
futur
potenti
optim
term
charg
shape
size
drive
ideal
respons
addit
display
antigen
compon
take
form
peptid
protein
qv
whether
linear
conform
conjug
best
promot
uptak
deliveri
present
viral
bacteri
antigen
immun
system
date
demonstr
sage
particl
act
success
scaffold
present
immunogen
peptid
compon
maintain
abil
seek
explor
whether
sage
use
novel
deliveri
system
drive
respons
whether
function
whole
protein
help
strengthen
respons
final
whether
continu
peptid
function
whole
protein
next
import
step
use
sage
scaffold
effect
protect
infect
challeng
peptid
synthesi
peptid
synthes
use
liberti
blue
microwav
peptid
synthes
cem
mathew
usa
mmol
scale
use
fmoc
chemistri
coupl
perform
use
n
n
dmf
dmf
morpholin
dmf
deprotect
instanc
deprotect
condit
two
treatment
w
dmf
wash
cy
residu
coupl
condit
w
follow
w
arg
residu
coupl
condit
w
follow
w
residu
coupl
condit
w
sage
assembl
hub
variant
dissolv
desir
concentr
desir
buffer
left
min
mix
assembl
one
variant
exampl
two
hubb
variant
fitcsag
two
mix
left
min
introduc
partner
hub
compon
mix
hub
allow
assembl
h
conduct
character
experi
cd
spectroscopi
cd
spectra
obtain
use
jasco
spectropolarimet
fit
peltier
temperatur
control
solut
prepar
pb
ph
examin
mm
quartz
cuvett
thermal
denatur
experi
perform
increas
temperatur
rate
spectra
measur
interv
cd
nm
record
interv
nm
interv
nm
bandwidth
respons
time
raw
data
mdeg
normal
peptid
concentr
path
length
number
amid
bond
give
mre
deg
melt
temperatur
obtain
intercept
second
deriv
plot
mre
nm
temperatur
scan
electron
microscopi
hub
prepar
pb
ph
mix
ratio
allow
sage
assembl
h
final
total
peptid
concentr
assembl
sage
deposit
onto
stub
left
overnight
air
dri
sputter
coat
goldpalladium
emitech
deposit
layer
nm
thick
imag
obtain
use
fei
oregon
usa
quanta
instrument
ast
assay
toxic
studi
ast
evalu
whole
blood
sampl
test
colorimetr
method
use
konelab
prime
thermo
fisher
cellular
uptak
fluoresc
sage
differenti
mdm
mddc
seed
equal
densiti
per
well
plate
cell
wash
pb
prior
addit
fluorescein
isothiocyan
fitc
final
concentr
function
particl
fitcsag
left
untreat
min
cell
harvest
ice
manual
detach
divid
two
sampl
trypan
blue
ad
one
sampl
vv
final
concentr
min
prior
flow
cytometr
acquisit
order
quench
extern
fluoresc
flow
cytometri
perform
use
lsrfortessa
bd
bioscienc
san
diego
us
analysi
unquench
versu
quench
sampl
perform
use
flowjo
softwar
bd
bioscienc
uptak
sage
measur
geomean
fluoresc
cell
prolifer
assay
sage
experi
healthi
donor
age
recruit
studi
peripher
blood
obtain
individu
studi
approv
local
research
ethic
committe
part
univers
bristol
immun
infect
research
tissu
bank
nh
rec
licens
inform
written
consent
obtain
donor
case
human
pbmc
murin
splenocyt
grown
plate
corn
uk
presenc
sage
pha
sigma
media
place
humidifi
environ
day
cultur
triplic
sampl
resuspend
cell
cultur
plate
round
bottom
plate
corn
uk
cultur
puls
perkin
elmer
uk
overnight
harvest
use
harvest
tomtec
usa
assess
incorpor
use
wallac
trilux
counter
perkin
elmer
uk
prolifer
calcul
mean
correct
count
per
minut
cpm
triplic
sage
equival
total
peptid
respect
immun
sage
balbc
mice
jackson
laboratori
charl
river
uk
limit
use
femal
mice
hous
specif
pathogen
free
condit
univers
bristol
anim
servic
unit
use
week
age
experi
conduct
complianc
uk
home
offic
regul
mice
immun
subcutan
termin
spleen
excis
anim
siev
seri
cell
strainer
bd
bioscienc
gener
suspens
murin
splenocyt
ex
vivo
prolifer
assay
harvest
centrifug
splenocyt
reconstitut
media
lonza
slough
uk
cell
stimul
either
sage
ova
peptid
antibodi
titer
sage
ova
evalu
use
end
point
titer
immunosorb
assay
ept
elisa
cell
prolifer
assay
carri
vitro
experi
label
cell
ctv
prolif
assay
perform
label
cell
cell
replic
track
ctv
thermo
fisher
enrich
cell
resuspend
cell
pb
ctv
ad
incub
dark
min
label
quench
cm
cell
left
settl
min
room
temperatur
resuspend
cm
vitro
cultur
cell
pb
vivo
experi
cell
per
mous
adopt
transfer
cell
immun
vivo
week
old
balbc
tcr
transgen
mice
recogn
epitop
bred
environ
univers
bristol
anim
servic
unit
balbc
mice
charl
river
uk
limit
use
experi
conduct
accord
current
uk
home
offic
regul
cell
label
ctv
resuspend
pb
cell
pb
balbc
mice
inject
iv
cell
cell
iv
per
mous
ha
peptid
subcutan
dorsal
neck
scruff
subcutan
dorsal
neck
scruff
gave
ng
dose
ha
epitop
mice
assign
treatment
manner
design
elimin
batch
effect
spleen
extract
mice
process
enrich
cell
stain
viabil
cell
surfac
marker
statist
analysi
statist
analys
graphic
present
perform
use
graphpad
prism
softwar
signific
mddc
uptak
sage
determin
way
anova
test
n
donor
signific
prolif
respons
sage
determin
test
n
donor
signific
immun
sage
determin
test
n
donor
signific
prolif
respons
immun
determin
use
welch
test
arcsin
squar
root
transform
data
asterisk
indic
signific
differ
p
p
p
author
declar
conflict
interest
